The MedicX Fund Limited - Notification of Major Interests in Shares




TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ			Medicx Fund Ltd
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Increase in total voting rights following Placing, Open Offer and Offer for Subscription			X
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ		Rensburg Sheppards Investment Management Limited
4. Full name of shareholder(s) (if different from 3.):^iv		N/A
5. Date of the transaction and date on which the threshold is crossed or reached: ^v		12^th March 2010
6. Date on which issuer notified:		16^th March 2010
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}		17%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

Ordinary Shares

GG00B1DVQL92

24,228,316

24,209,216

17.38%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,209,216

17.38%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi
Client holdings registered in the name of Nominee companies 100% owned by Rensburg Sheppards Investment Management Limited.

Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A

13. Additional information:	N/A
14. Contact name:	N/A
15. Contact telephone number:	N/A

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	Rensburg Sheppards Investment Management Limited
Contact address (registered office for legal entities)	Quayside House Canal Wharf Leeds LS11 5PU
Phone number & email	0113 236 4171 mike.rigby@rsim.co.uk
Other useful information (at least legal representative for legal persons)	Mike Rigby (Head of Compliance)

B: Identity of the notifier, if applicable
Full name	Philip Martin Beardwell
Contact address	2 Gresham Street London EC2V 7QN
Phone number & email	020 7597 1356 phil.beardwell@rsim.co.uk
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Senior Compliance Manager

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.